Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  pemetrexed disodium
Find trials that include:  Any drugs shown
Results 1-25 of 39 for your search:
Start Over
Phase IIB/III Of TG4010 Immunotherapy In Patients With Stage IV Non-Small Cell Lung Cancer
Phase: Phase III, Phase II
Type: Treatment
Age: 18 and over
Trial IDs: TG4010.14/TIME, NCI-2013-00825, 8559, TG4010.14/TIME, 8559, NCT01383148
Immunotherapy Study in Progressive or Relapsed Non-Small Cell Lung Cancer
Phase: Phase III, Phase II
Type: Treatment
Age: 18 and over
Trial IDs: NLG0301, NCI-2013-00592, 1209-1184, NCT01774578
LDK378 Versus Chemotherapy in ALK Rearranged (ALK Positive) Patients Previously Treated With Chemotherapy (Platinum Doublet) and Crizotinib
Phase: Phase III
Type: Treatment
Age: 18 and over
Trial IDs: CLDK378A2303, NCI-2014-00520, 2012-005637-36, NCT01828112
Study of Pembrolizumab (MK-3475) Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (MK-3475-024/KEYNOTE-024)
Phase: Phase III
Type: Treatment
Age: 18 and over
Trial IDs: 3475-024, NCI-2014-01865, 142728, 2014-000323-25, NCT02142738
Intensity-Modulated Radiation Therapy, Pemetrexed Disodium, and Erlotinib Hydrochloride in Treating Patients With Recurrent or Second Primary Head and Neck Cancer
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: CCCWFU 60107, NCI-2009-01250, CCCWFU-IRB00003457, CDR0000578838, LILLY-CCCWFU-60107, NCT01580449, P30CA012197, NCT00573989
Panobinostat and Pemetrexed Disodium in Treating Patients With Previously Treated Advanced Non-Small Cell Lung Cancer
Phase: Phase II, Phase I
Type: Treatment
Age: 18 and over
Trial IDs: 08-036, NCI-2011-02483, NCT00907179
Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural Mesothelioma
Phase: Phase II, Phase I
Type: Tissue collection/Repository, Treatment
Age: 18 and over
Trial IDs: S0905, NCI-2011-02015, CDR0000665415, SWOG-S0905, NCT01064648
A Study of Pembrolizumab (MK-3475) in Combination With Chemotherapy or Immunotherapy in Participants With Lung Cancer (MK-3475-021/KEYNOTE-021)
Phase: Phase II, Phase I
Type: Treatment
Age: 18 to 75
Trial IDs: 3475-021, NCI-2014-00482, NCT02039674
Itraconazole and Pemetrexed Disodium in Treating Patients With Previously Treated Non-Small Cell Lung Cancer
Phase: Phase II
Type: Supportive care, Treatment
Age: Over 18
Trial IDs: J0881, NCI-2010-02070, NCT00769600
Carboplatin, Pemetrexed Disodium, and Bevacizumab in Treating Patients With Stage IIIB-IV Lung Cancer With a Light or Never Smoking History
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: LCCC 0825, NCI-2013-01055, 09-0774, AVF4499s, UNC-LCCC-0825, NCT01344824
Pemetrexed Disodium or Observation in Treating Patients with Malignant Pleural Mesothelioma without Progressive Disease after First-Line Chemotherapy
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: CALGB 30901, NCI-2011-02023, CDR0000667496, NCT01085630
GSK1120212 Rollover Study
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 114375, NCI-2011-03211, NCT01376310
Afatinib Dimaleate, Combination Chemotherapy, and Radiation Therapy in Treating Patients with Stage III Non-small Cell Lung Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 11-464, NCI-2012-01535, 1200.158, NCT01553942
Study of TH-302 or Placebo in Combination With Pemetrexed in Patients With Non-squamous Non-small Cell Lung Cancer
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: TH-CR-415, NCI-2014-01327, NCT02093962
Ruxolitinib in Combination With Pemetrexed/Cisplatin in Non Small Cell Lung Cancer
Phase: Phase II
Type: Treatment
Age: 18 to 75
Trial IDs: INCB 18424-266, NCI-2014-01067, NCT02119650
Pemetrexed Disodium with or without Crizotinib in Treating Patients with Stage IV Non-small Cell Lung Cancer That Has Progressed after Treatment with Crizotinib Alone
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: S1300, NCI-2014-00685, NCT02134912
Cisplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation before Surgery in Treating Patients with Stage IIIA Non-small Cell Lung Cancer
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: LCCC 1407, NCI-2015-00192, 14-2146, NCT02276560
Personalized Therapy Using Genetic Markers in Treating Patients with Esophagogastric Cancer That Is Metastatic or Cannot Be Removed by Surgery
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 201412051, NCI-2014-02550, NCT02296671
A Study of MM-121 in Combination With Chemotherapy Versus Chemotherapy Alone in Heregulin Positive NSCLC
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: MM-121-01-02-09, NCI-2015-00560, NCT02387216
Azacitidine and Entinostat before Chemotherapy in Treating Patients with Advanced Non-small Cell Lung Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: NA_00081948/J1309, NCI-2013-00949, NA_00081948, NCT01846897, 9253, NCT01935947
Pemetrexed Disodium in Treating Patients with Recurrent Primary or Secondary CNS Lymphoma
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: 06-097, NCI-2010-00048, H3E-US-X059, NCT00916630
Start Over